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Abstract
Introduction: During critical illness, oliguria is often used as a biomarker of acute kidney injury (AKI). However, its
relationship with the subsequent development of AKI has not been prospectively evaluated.
Methods: We documented urine output and daily serum creatinine concentration in patients admitted for more
than 24 hours in seven intensive care units (ICUs) from six countries over a period of two to four weeks. Oliguria
was defined by a urine output < 0.5 ml/kg/hr. Data were collected until the occurrence of creatinine-defined AKI
(AKI-Cr), designated by RIFLE-Injury class or greater using creatinine criteria (RIFLE-I[Cr]), or until ICU discharge.
Episodes of oliguria were classified by longest duration of consecutive oliguria during each day were correlated
with new AKI-Cr the next day, examining cut-offs for oliguria of greater than 1,2,3,4,5,6, or 12 hr duration,
Results: We studied 239 patients during 723 days. Overall, 32 patients had AKI on ICU admission, while in 23, AKI-
Cr developed in ICU. Oliguria of greater than one hour was significantly associated with AKI-Cr the next day. On
receiver-operator characteristic area under the curve (ROCAUC) analysis, oliguria showed fair predictive ability for
AKI-Cr (ROCAUC = 0.75; CI:0.64-0.85). The presence of 4 hrs or more oliguria provided the best discrimination
(sensitivity 52% (0.31-0.73%), specificity 86% (0.84-0.89%), positive likelihood ratio 3.8 (2.2-5.6), P < 0.0001) with
negative predictive value of 98% (0.97-0.99). Oliguria preceding AKI-Cr was more likely to be associated with lower
blood pressure, higher heart rate and use of vasopressors or inotropes and was more likely to prompt clinical
intervention. However, only 30 of 487 individual episodes of oliguria preceded the new occurrence of AKI-Cr the
next day.
Conclusions: Oliguria was significantly associated with the occurrence of new AKI-Cr, however oliguria occurred
frequently compared to the small number of patients (~10%) developing AKI-Cr in the ICU, so that most episodes
of oliguria were not followed by renal injury. Consequently, the occurrence of short periods (1-6 hr) of oliguria
lacked utility in discriminating patients with incipient AKI-Cr (positive likelihood ratios of 2-4, with > 10 considered
indicative of a useful screening test). However, oliguria accompanied by hemodynamic compromise or increasing
vasopressor dose may represent a clinically useful trigger for other early biomarkers of renal injury.
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Introduction
Urine output monitoring is almost universal in critically
ill patients worldwide. Historically, maintenance of urine
output has been regarded as being synonymous with the
preservation of renal function and decreases in urine
output regularly prompt a variety of clinical
interventions with the aim of preventing or attenuating
acute kidney injury (AKI) [1]. According to this para-
digm, after exclusion of obstruction, decreased urine
output is considered a clinically useful biomarker of
decreased glomerular filtration rate (GFR), which occurs
before the detectable accumulation of biochemical mar-
kers of AKI. As a result, consensus definitions of AKI
have incorporated urine output criteria alongside bio-
chemical markers of renal excretory function [2,3].
Unfortunately, this step has occurred despite a lack of
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any prospective data in critically ill patients associating
the magnitude and duration of oliguria with subsequent
changes in serum biochemistry. In addition, urine out-
put criteria used in consensus definitions have ignored
the potential value of shorter periods of oliguria.
It is important to note that Risk, Injury, Failure, Loss,
End-Stage (RIFLE) and Acute Kidney Injury Network
(AKIN) consensus definitions of AKI incorporate
lengthy periods of oliguria (6, 12, and 24 hours) by
which time significant renal injury may have already
occurred. Consequently, much shorter durations of oli-
guria, such as two hours or less [4], have been recom-
mended and are often used as targets for therapeutic
intervention. It is uncertain, however, how many
patients experiencing shorter periods of oliguria are at
significant risk of biochemical AKI defined by creatinine
criteria (AKI-Cr). Furthermore, it is unclear how sensi-
tive any duration of oliguria is at identifying AKI-Cr
given that urine output can be relatively preserved even
when GFR is significantly impaired [5,6]. Accordingly,
we hypothesized that oliguria would only be a poor to
fair predictive biomarker of subsequent AKI-Cr. To test
this hypothesis, we performed a prospective multicenter
observational study of the relation between oliguria and
subsequent AKI-Cr in a cohort of critically ill patients
in seven centers worldwide.
Materials and methods
Study population and methodology
Local Ethics Committee approval was obtained for
anonymous analysis of routinely collected clinical data
with waiver of informed consent. A case report form
was generated centrally and distributed to experienced
center lead investigators who supervised the local data-
collection process. We documented hourly urine output
and daily serum creatinine (sCr) in unselected consecu-
tive ICU admissions of at least one calendar day in
seven adult ICUs from six countries over periods of two
weeks (six centers) or four weeks (one center) during
2008. Patients with end stage renal disease (on mainte-
nance dialysis) or without a urinary catheter were
excluded. Patient demographics, admission clinical
details, Simplified Acute Physiology Score (SAPS II) ill-
ness severity scoring [7] on ICU admission and bio-
chemistry were also documented. Patients were defined
as medical or surgical by nature of admitting clinical
service. Sepsis during ICU admission was defined as the
presence of a systemic inflammatory response syndrome
(SIRS) response in the context of proven or suspected
infection [8]. Following RIFLE and AKIN criteria, oli-
guria was identified as consecutive hours of urine output
of less than 0.5 ml/kg body weight. AKI-Cr was defined
as new RIFLE Injury or greater, using the sCr criteria of
the RIFLE consensus definition - a doubling of sCr from
pre-morbid baseline (RIFLE I[Cr]). The intention of this
study was to assess the ability of varying periods of
reduced urine output to predict biochemical evidence of
renal dysfunction. Thus, only creatinine criteria of the
RIFLE consensus definition of AKI were used to define
outcome. Where pre-morbid biochemical data was not
available, a baseline sCr was estimated assuming a GFR
of 75 ml/min as previously described [9]. One patient
received renal replacement therapy (RRT) for ongoing
anuria prior to meeting biochemical criteria for RIFLE-I
and was analyzed as developing AKI-Cr. Data were col-
lected until the occurrence of AKI-Cr defined as RIFLE
I[Cr] or greater or ICU discharge, oliguria during days
in ICU after the occurrence of AKI-Cr were not
included. Episodes of oliguria during each 24-hour per-
iod were correlated with the occurrence of new RIFLE I
[Cr] or greater on routine morning bloods the next day.
We considered that more sustained oliguria may reflect
extended periods of renal hemodynamic compromise
and might better predict biochemically evident renal
dysfunction. Thus, we sought to correlate the maximum
duration of consecutive oliguria on any given ICU day
with the occurrence of new RIFLE I[Cr] or greater on
routine bloods the next morning. We secondarily
assessed the predictive ability of oliguria in each of the
two days preceding AKI-Cr and repeated our original
analysis limiting data to that collected on the first three
ICU days only.
For each individual episode of oliguria basic hemody-
namic variables at the beginning of the episode and any
clinician response to oliguria (fluid, vasoactive drug, or
diuretic prescription) were recorded and comparison
was made between episodes of oliguria that were and
were not associated with progression to RIFLE I[Cr] the
next day. In this analysis individual episodes of oliguria
were treated as discrete events. This is because two dif-
ferent episodes of oliguria occurring on the same day
might have occurred in different hemodynamic contexts
and prompted different interventions. Clinical interven-
tions were deemed to be associated with oliguria if they
occurred during or within one hour of the end of a per-
iod of oliguria.
Data handing and statistical analysis
Data were collected and collated using Microsoft Excel
(Microsoft Corp, Redmond, WA, USA). Categorical vari-
ables were compared using Fisher’s exact test, continu-
ous data were reported as median with inter-quartile
range (IQR) and compared using the Mann-Whitney U
test. Receiver-operator characteristic (ROC) curve analy-
sis was used to assess the ability of varying duration of
the longest period of oliguria to predict the occurrence
of RIFLE I[Cr] or greater the next day. Univariate statis-
tics, ROC curve analysis and area under curve (AUC)
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calculation was carried out using GraphPad Prism ver-
sion 5.0 d for Mac OS (GraphPad Software, La Jolla,
CA) [10] additionally binomially fitted ROC curves and
asymmetric 95% confidence intervals were prepared
using ROC analysis: web-based calculator for ROC
curves [11]. We defined an ROCAUC of 0.5 to 0.6 as
showing no predictive ability, an ROCAUC of 0.6 to 0.7
as showing poor predictive ability, an ROCAUC of 0.7
to 0.8 as showing fair predictive ability, an ROCAUC of
0.8 to 0.9 as showing good predictive ability, and an
ROCAUC above 0.9 as showing outstanding predictive
ability for AKI-Cr.
Results
Patient characteristics
We studied 239 patients during 723 ICU days (Table 1).
Pre-morbid sCr was available in 59.8% of patients and
was estimated in 40.2%. Weight was measured at hospi-
tal admission in 69.5% and estimated in the ICU by
local protocol in 30.5%.
Overall, 28-day mortality was 10.7% and 54 (22.5%)
patients had sCr criteria for RIFLE I[Cr] or greater. Of
these, 32 (13.4%) had AKI-Cr on ICU admission and were
not considered further, whereas in 23 individuals (9.6%),
new AKI-Cr developed in ICU. Overall, of the 293 patients,
21 (8.8%) received RRT in the ICU. Of the 54 patients with
AKI-Cr, 21 (39%) received RRT; however, of the 23 patients
developing AKI-Cr in the ICU only five received RRT, this
is 22% of AKI-Cr in ICU. On the other hand, 50% of
patients with AKI-Cr on admission required RRT. The
median day of AKI-Cr occurring in the ICU was day three
(range second to fourth ICU day). The relation between
type of admission (medical/surgical), or diagnosis of sepsis
and the occurrence of AKI-Cr on admission or in the ICU
is shown in Table 2. Significantly more patients with AKI-
Cr on ICU admission had a diagnosis of sepsis (P = 0.015)
while more patients who developed AKI-Cr in the ICU
were surgical than medical (P = 0.05).
Oliguria occurring prior to diagnosis of AKI-Cr
Episodes of oliguria of one hour or more occurred on
265 of 723 study days and were significantly associated
with the occurrence of new AKI-Cr on the next day
(Table 3). However, on 257 days (38%), oliguria of one
hour or more occurred without progression to RIFLE of
one or more the next day. Most episodes of oliguria,
regardless of duration, were not closely followed by
renal injury. Indeed, on 9 of 13 occasions, greater than
12 hours of consecutive oliguria (oliguria ≥12 hour)
(RIFLE I by urine output criteria) occurred without
development of RIFLE-I by sCr criteria the next day
(Table 3). Many patients developing AKI-Cr did not
have prolonged periods of oliguria on the day prior to
diagnosis of AKI-Cr, with only 52% (12 of 23) of such
patients experiencing oliguria for four or more hours
during the preceding day and 5 of 22 patients progres-
sing to RIFLE I without any oliguria the preceding day.
Ability of oliguria to predict AKI-Cr
The ROCAUC for oliguria as a predictor of subsequent
AKI-Cr (Figure 1) showed a statistically significant, but
only fair performance (ROCAUC = 0.75, 95% confidence
interval (CI) 0.64-0.85). On balance, oliguria of four or
more hours provided best overall combination of sensi-
tivity and specificity (Sensitivity 52%, 95% CI 0.31-0.73;
Specificity 86%, 95% CI 0.84-0.8; positive likelihood ratio
3.8, 95% CI 2.2-5.6; P < 0.0001). However, even with
this degree of oliguria, the positive predictive value for
AKI-Cr was only 11% (95% CI 6-19%; Table 3). For all
levels of oliguria, there were strong negative predictive
values (all > 97%) reflecting the low daily incidence of
AKI-Cr. When analyzing medical and surgical ICU
admissions separately, AKI-Cr in the ICU was more
common in surgical patients (Table 2). However, oli-
guria appeared no better at predicting AKI-Cr in surgi-
cal admissions (ROCAUC = 0.73, 95% CI 0.59-0.87,
Figure 2) than in medical patients (ROCAUC = 0.79,
Table 1 Patient characteristics
No. Male Surgical Sepsis SAPS 2 AKI on admission AKI in ICU RRT 28-Day
mortality
Australia 88 58% 57% 34% 31 11 10 6 15%
Canada 31 59% 25% 68% 45 13 0 7 22%
Japan 1 16 69% 75% 19% 31 1 2 1 0%
Japan 2 15 40% 93% 6% 25 0 0 0 6.3%
USA 34 50% 12% 32% na 3 1 3 12%
Germany 35 66% 17% 37% 34 4 5 4 8.5%
Italy 19 74% 100% 0% 29 0 5 0 0%
All 239 59% 48% 34% 31 32 22 21 11%
Study centers: Austin Hospital, Heidelberg, Victoria, Australia (R. Bellomo), University of Alberta Hospital, Calgary, Alberta, Canada (S. Bagshaw), Charité University
Medicine, Potsdam, Germany (M. Haase), Okayama University Hospital, Shikata City, Japan (M. Egi), Jikei University School of Medicine, Tokyo, Japan (S. Uchino),
UPMC McKeesport, Pittsburgh, PA, USA (J. Kellum) and Ospedale San Bortolo, Vicenza, Italy (C. Ronco).
AKI, acute kidney injury; na, not available; RRT, renal replacement therapy; SAPS 2, simplified acute physiology score 2.
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95% CI 0.63-0.94, Figure 3). Similarly, there was no sig-
nificant difference in predictive ability for admissions
with sepsis (ROCAUC = 0.78, 95% CI 0.64-0.90, Figure
4). Estimated baseline creatinine was used to define
AKI-CR in 40% of patients, this may have led to an
over- or under-estimate of the incidence of AKI-Cr in
these patients. However, exclusion of all individuals with
estimated baseline creatinine did not improve the diag-
nostic ability of oliguria to predict AKI-Cr in ROC ana-
lysis with a ROCAUC of 0.71 (0.54-0.87) when
considering only patients with documented baseline
creatinine.
Extension of the time period during which the occur-
rence of oliguria could predict AKI-Cr from the day
preceding to the two days preceding AKI-Cr did not
improve the ability of oliguria to discriminate AKI-Cr
(Table 4) and the ROCAUC for this comparison was
0.72 (0.63-0.81).
Most AKI-Cr in the ICU occurred in the first few
days of critical illness. Inclusion of repeated measures
of urine output over many days of lengthy ICU admis-
sion might lead to some stable patients at low risk of
AKI being over-represented in the dataset. We
repeated our initial analysis including urine output
during the first three days of ICU stay only in all
patients with a longer length of stay (Table 5). Again,
predictive ability of oliguria did not improve in this
analysis with an ROCAUC of 0.72 (0.61-0.83) because,
even in patients who did not develop AKI-Cr, most
days of oliguria occurred early in ICU admission
(Tables 3 and 5).
Looking at oliguria occurring at any stage prior to a
diagnosis of AKI-Cr in the ICU, in all 207 patients at
risk, 130 (63%) experienced at least one episode of oli-
guria. Only 20 (15%) of these patients actually developed
RIFLE I AKI-Cr. Conversely of the 77 patients with no
oliguria, only three (3.9%) developed AKI-Cr (sensitivity
87%, 95% CI 0.66-0.97; specificity 40%, 95% CI 0.33-
0.47; positive likelihood ratio 1.5, 95% CI 1.1-1.6; Fish-
er’s exact test: P = 0.011).
Individual episodes of oliguria and relation to occurrence
of AKI-Cr
A total of 487 individual episodes of oliguria were
recorded in patients at risk of AKI-Cr. Only 30 of these
were associated with progression to RIFLE I[Cr] AKI-Cr
the next day. Duration of oliguria was not significantly
greater in those developing AKI-Cr. However, in uni-
variate analysis, patients developing AKI-Cr had higher
heart rate, lower blood pressure, higher central venous
pressure and were more likely to be on vasopressor or
inotropic medication. Oliguria preceding AKI-Cr was
Table 2 Relation between admitting service and sepsis diagnosis with AKI-Cr on ICU admission and AKI-Cr in the ICU
All Admissions Admissions ith AKI-Cr P Admissions without AKI-Cr AKI-Cr in ICU P
Medical 125 19
(15%, 9-22%)
0.45 106 7
(5.6%, 1.5-10%)
0.05
Surgical 114 13
(11%, 5-17%)
101 16
(14%, 8-21%)
Sepsis 80 17
(21%, 12-30%)
0.015 63 9
(11%, 4-18%)
0.35
No Sepsis 159 15
(9.4%, 5-14%)
143 14
(8.8%, 4-13%)
Percentages are percent patients developing AKI of all admissions in that category with 95% confidence intervals. AKI-Cr, acute kidney injury defined by changes
in serum creatinine.
Table 3 Relation between length of longest episode of oliguria during an ICU day at risk (patient day without a
diagnosis of RIFLE I[Cr]) and AKI-Cr the next day
Longest duration of oliguria Days with AKI-Cr
next day
Days with no AKI-Cr
next day
Sens. Spec. PPV NPV LR P RR of AKI-Cr
None 5 443
≥1 hr 18 257 0.78 0.63 0.07 0.99 2.1 < 0.0001 5.9
≥2 hr 15 194 0.65 0.72 0.07 0.98 2.4 0.0003 4.6
≥3 hr 13 125 0.57 0.82 0.09 0.98 3.2 < 0.0001 5.5
≥4 hr 12 95 0.52 0.86 0.11 0.98 3.8 < 0.0001 6.3
≥5 hr 7 75 0.30 0.89 0.09 0.98 2.8 0.01 3.4
≥6 hr 5 50 0.21 0.93 0.09 0.97 3.1 0.02 3.8
≥12 hr 4 9 0.17 0.99 0.31 0.97 13.5 0.0005 11.5
P-values refer to Fisher’s exact test for presence or absence of stated degree of oliguria and AKI outcome.
AKI-Cr, acute kidney injury defined by changes in serum creatinine; hr, hours; LR, likelihood ratio (positive); NPV, negative predictive value; PPV, positive
predictive value; Sens, sensitivity; Spec, specificity; RR, relative risk.
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also more likely to receive physician intervention with
diuretics or fluid therapy (Table 6).
Discussion
Statement of key findings
We performed a prospective, multicenter, multina-
tional observational study to assess the association
between oliguria and the subsequent development of
AKI-Cr in cohort of medical and surgical critically ill
adults. We sought to test the hypothesis that oliguria
would only be a poor to fair predictive biomarker of
subsequent AKI-Cr. We found that more patients pre-
sented to the ICU with AKI-Cr rather than develop it
in the ICU. We also found that even the shortest
duration of oliguria of one hour was significantly asso-
ciated with the development of AKI-Cr in the ICU.
However, AKI-Cr was infrequent and oliguria was
relatively common, with some degree of oliguria
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Figure 1 Receiver-operator characteristic analysis of the ability
of varying durations of oliguria to predict RIFLE Injury (I) or
more the next day. Receiver-operator characteristic (ROC) area
under the curve = 0.75, 95% confidence interval (CI) 0.64-0.85.
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Figure 2 Receiver-operator characteristic analysis of surgical
patients. Receiver-operator characteristic (ROC) area under the
curve = 0.73, 95% confidence interval (CI) 0.59-0.87.
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
False Positive Fraction
Tr
ue
 P
os
iti
ve
 F
ra
ct
io
n
Fitted ROC
95% CI
Empiric ROC
Figure 3 Receiver-operator characteristic analysis of medical
patients. Receiver-operator characteristic (ROC) area under the
curve = 0.79, 95% confidence interval (CI) 0.63-0.94).
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Figure 4 Receiver-operator characteristic analysis of patients
with a diagnosis of sepsis. Receiver-operator characteristic (ROC)
area under the curve = 0.78, 95% confidence interval (CI) 0.64-0.90).
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occurring on one third of days spent in the ICU in
patients without a diagnosis of AKI-Cr. This high
false-positive rate precluded the use of oliguria alone
for the early identification of AKI-Cr. Conversely,
many patients developing AKI-Cr did not have pro-
longed periods of oliguria the day before diagnosis of
AKI-Cr, with only half of AKI-Cr patients experien-
cing oliguria of four hours or more the preceding day
and approximately one quarter of 23 patients progres-
sing to AKI-Cr without any oliguria the preceding
day. Oliguria preceding AKI-Cr was more likely to be
associated with lower blood pressure, higher heart
rate, and use of vasopressors or inotropes, and was
more likely to prompt intervention suggesting that
hemodynamic status and other factors affecting physi-
cian decisionmaking might add to the predictive abil-
ity of oliguria. However, only 6.2% of episodes of
oliguria of one hour or more were associated with
AKI-Cr the next day.
Comparison with previous studies
To our knowledge this is the first study to prospectively
assess the value of varying durations of urine output as
a predictive biomarker of AKI-Cr in ICU. Thus, its find-
ings cannot be directly compared with previous studies.
However, the issue of oliguria in humans has been
explored in the past. In particular, modern concepts of
oliguria date back to studies from the 1930s and 1940s
examining urine output during fasting in normal indivi-
duals [12-14]. In these studies, maximal water conserva-
tion achieved a minimal urine output of about 500 ml
per day in adults or 0.5 ml/kg/hr in children. Thus, in
normal individuals, such urine output was achievable by
urinary concentration, but, below this value, a decreas-
ing urine output was linearly related to decreasing GFR
as maximum urinary concentration had been achieved
[14]. By the 1950s, these results had given rise to the
concept that sustained oliguria implied a significant
decrease in renal excretory function [15].
Table 4 Relation between length of longest episode of oliguria during an ICU day at risk (patient day without a
diagnosis of RIFLE I[Cr]) and AKI-Cr in the next two days
Longest duration of oliguria Days with AKI-Cr next
2 days
Days with no AKI-Cr next 2 days Sens. Spec. PPV NPV LR P RR of AKI
None 9 439
≥1 hr 26 249 0.74 0.63 0.09 0.98 2.1 < 0.001 4.7
≥2 hr 22 187 0.62 0.72 0.10 0.97 2.3 < 0.001 4.2
≥3 hr 18 120 0.51 0.83 0.13 0.97 2.9 < 0.001 4.5
≥4 hr 17 90 0.49 0.87 0.16 0.97 3.7 < 0.001 5.4
≥5 hr 10 72 0.29 0.90 0.12 0.96 2.7 0.004 3.1
≥6 hr 6 49 0.17 0.93 0.11 0.96 2.4 0.04 2.5
≥12 hr 4 9 0.11 0.99 0.31 0.96 8.7 0.002 7.0
Receiver-operator characteristic area under the curve for this comparison = 0.72 (0.63-0.81). P-values refer to Fisher’s exact test for presence or absence of stated
degree of oliguria and AKI outcome.
AKI-Cr, acute kidney injury defined by changes in serum creatinine; LR, likelihood ratio (positive); NPV, negative predictive value; PPV, positive predictive value;
Sens, sensitivity; Spec, specificity; RR, relative risk.
Table 5 Relation between length of longest episode of oliguria during an ICU day at risk (patient day without a
diagnosis of RIFLE I[Cr]) and AKI-Cr in the next day considering only data gathered during the first three days of ICU
admission
Longest duration of oliguria Days with AKI-Cr
next day
Days with no AKI-Cr
next day
Sens. Spec. PPV NPV LR P RR of AKI-Cr
None 5 238
≥1 hr 18 175 0.78 0.57 0.09 0.98 1.9 < 0.001 4.5
≥2 hr 15 130 0.68 0.69 0.10 0.98 2.2 < 0.001 4.3
≥3 hr 13 91 0.56 0.78 0.13 0.97 2.6 < 0.001 4.2
≥4 hr 12 71 0.52 0.83 0.14 0.97 3.0 < 0.001 4.6
≥5 hr 7 59 0.30 0.85 0.11 0.96 2.1 0.06 2.5
≥6 hr 5 40 0.22 0.90 0.11 0.95 2.2 0.08 2.4
≥12 hr 4 8 0.17 0.98 0.33 0.96 9.0 0.002 7.4
Receiver-operator characteristic area under the curve for this comparison = 0.72 (0.61-0.83). P-values refer to Fisher’s exact test for presence or absence of stated
degree of oliguria and AKI outcome.
AKI-Cr, acute kidney injury defined by changes in serum creatinine; LR, likelihood ratio (positive); NPV, negative predictive value; PPV, positive predictive value;
Sens, sensitivity; Spec, specificity; RR, relative risk.
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The concepts described above have been transferred
almost unaltered into the RIFLE and AKIN contempor-
ary consensus definitions of AKI [2,3]. In these systems,
urine output of less than 0.5 ml/kg/hr for 6 or 12 hours
is used to identify mild or intermediate kidney injury
(RIFLE R or I; AKIN 1 or 2) and a urinary output less
than 0.3 ml/kg/hr for more than 24 hours or anuria for
more than 12 hours is taken to identify more severe
AKI (RIFLE F; AKIN 3). The accuracy and usefulness of
this urinary classification in real world clinical contexts,
however, remains poorly understood. More relevant to
this study, many other factors may modify the relation
between urine output and GFR in critical illness. For
example, in both acute and chronic renal disease, urin-
ary concentrating capacity is often impaired [12] and
urinary concentrating capacity is directly related to the
kidney’s ability to reduce urea clearance in relation to
GFR [16]. Thus, although GFR may be significantly
lower, the ability to generate a low volume of urine may
be impaired. In these circumstances, a decline in GFR
will ultimately result in a decrease in urine output,
which may only meet conventional definitions of oli-
guria at very low levels of GFR making sustained oli-
guria a late and not early indicator of AKI. In addition,
AKI-Cr can occur in the absence of oliguria [5,17].
Moreover, this relation may be frequently distorted by
the administration of large amounts of intravenous
fluids, diuretics, vasopressor drugs, or any combination
of these. Conversely, oliguria can reflect salt and water
retention as a normal renal response to a mild or mod-
erate degree of hypovolemia or hypotension. Pain,
trauma, and surgery can trigger similar neuro-endocrine
responses resulting in oliguria in the absence of hemo-
dynamic compromise [18-21] and in the presence of
normal renal function [22].
Studies examining the application of sCr and urine
output criteria in the AKIN and RIFLE definitions of
AKI have shown that addition of the urine output cri-
teria (oliguria ≥6 hours) to sCr criteria can improve the
ability to predict mortality [23,24], but that urine output
criteria alone show a lower predictive ability than sCr
[25]. Macedo et al. [24] recently reported a prospectively
single-center study of oliguria in 75 medical ICU
patients, applying the AKIN criteria. In their study 24
(32%) patients had oliguria of six hours or more (< 0.5
ml/kg/hr) without developing AKIN-1 by sCr criteria
while four patients (5%) developed sCr criteria without
oliguria, and 17 patients (23%) had AKIN-1 AKI by both
criteria. These results are broadly in agreement with the
frequency of oliguria observed in our data and the
notion that, while the majority of cases of AKI-Cr are
associated with oliguria, significant periods (≥6 hours) of
oliguria occur frequently without subsequent elevation
of sCr even when using a much lower threshold for the
diagnosis of AKI (AKIN-1). However, the above study
did not assess the utility of oliguria as an earlier predic-
tor of AKI-Cr and did not examine the ability of shorter
periods of oliguria to predict AKI-Cr.
Significance of study findings
Our study provides the only prospective multicenter
assessment of oliguria in ICU to date. It shows that oli-
guria is, at best, only a fair predictor of subsequent AKI-
Cr. Notably all short durations of oliguria (< 12 hours)
were associated with positive likelihood ratios for AKI-
Cr of only two to four. This finding suggests that the
presence of these durations of oliguria during a given
day does not usefully increase the post-test probability
of AKI-Cr the next day, because, in general, a likelihood
ratio of more than 10 is considered necessary for a clini-
cally useful test [26,27].
Oliguria of 12 hours or more was associated with a
high enough likelihood ratio to have clinical utility, in
part validating its use in the RIFLE-Injury urine output
definition. However, use of this cut-off would result in
missing a large majority of cases of AKI-Cr. These
observations are important because identifying patients
at risk of developing AKI-Cr is the first and necessary
step for clinicians to decide which patients should
receive specific treatment and which patients should be
observed. The crucial importance of these distinctions is
supported by evidence that fluid resuscitation might
Table 6 Comparison of all individual episodes of oliguria
between those that were associated with progression to
RIFLE I[Cr] and those that were not
AKI-Cr No AKI-Cr P
Episodes of oliguria 30 457
Duration of oliguria 3 (1-4) 2 (1-3.75) 0.14
HR 90 (79-
100)
82 (70-95) 0.02
MAP 75 (65-80) 78 (70-
87.5)
0.01
CVP 11 (10-13) 9 (7-12) 0.02
On vasopressor or inotrope 65% (47-
82)
32% (28-
37)
0.0002
Action
None 17% (3-32) 52% (47-
57)
0.0002
Fluid 43% (25-
62)
26% (22-
30)
0.05
Diuretic 47% (28-
66)
26% (22-
30)
0.02
Increase/start vasopressor or
inotrope
17% (3-31) 24% (17-
30)
0.51
Continuous variables reported as medians and inter-quartile range and
compared with Mann-Whitney U test. Categorical variables are reported as
percentages with 95% confidence interval and compared with Fisher’s exact
test. AKI-Cr, acute kidney injury defined by changes in serum creatinine; CVP,
central venous pressure; HR, heart rate; MAP, mean arterial pressure.
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reduce renal dysfunction [28], but that iatrogenic fluid
overload can worsen outcomes [29-36] and the prog-
nosis of AKI [37,38]. In addition, the early identification
of patients at risk is vital because intervention only after
biochemical evidence of AKI has developed (increased
sCr) is likely to be too late. These clinical challenges are
further complicated by the likelihood that the transition
to renal dysfunction will not be abrupt. This gradual
transition from appropriate physiological salt and water
retention to injury is reflected in the limited diagnostic
utility of urinary biochemistry in the early diagnosis of
AKI the ICU [39].
Our data indicate that, if, for example, oliguria of two
hours or more was used to trigger further fluid resusci-
tation, some patients might receive unnecessary fluid
therapy, whereas others who might benefit from such
intervention might not receive it. Thus, while clinically
helpful, oliguria should be interpreted with caution in
isolation, but may be more usefully interpreted in the
clinical context as a screening test to direct additional
methods for early detection of renal injury [40-42].
Another important observation from our study is that
more patients had biochemically overt AKI on ICU
admission than developed it in the ICU. This finding
suggests the renal component of critical illness develops
outside the ICU in most patients and that oliguria
might be a more useful screening test in the pre-ICU
environment. However, patients outside the ICU rarely
have hourly documentation of urine output. Surgical
patients may be more likely to have monitoring of urine
output and develop AKI-Cr in the ICU. However, oli-
guria appeared, if anything, less predictive of AKI-Cr in
this group - perhaps because transient postoperative oli-
guria is a common and relatively benign response to
surgery.
Study strengths and limitations
Strengths of this study include that it is the first study
to investigate a common and important aspect of critical
illness, its prospective design, and representation of a
diverse population of critically ill patients from several
countries and a variety of ICU settings. Thus, these
results are likely to be widely applicable. On the other
hand, a number of patients had their baseline sCr and/
or body weight estimated, however, estimates are routi-
nely used in clinical decisionmaking and such use seems
appropriate when studying the real-world performance
of oliguria and exclusion of all patient with estimated
baseline creatinine did not materially affect the predic-
tive ability of oliguria. Some clinicians might consider
the choice of RIFLE I or greater as a threshold for diag-
nosis of AKI-Cr somewhat conservative, as smaller
increments in serum creatinine may be associated with
adverse outcomes. However, we wished to choose a
severity of AKI-Cr that was clearly clinically significant
and the potential target of interventional trials. The tim-
ing of observation with respect to the diagnosis of AKI-
Cr could also be criticised. However, a rising sCr during
a 24-hour period implies a fall in GFR. It is during this
period that oliguria might be expected to occur most
frequently and act as an early biomarker of patients
with evolving AKI-Cr. Clinical management of patients
was unaffected by any aspect of this study. Thus, epi-
sodes of oliguria may have triggered a variety of changes
in treatment that might have averted the development
of AKI-Cr. However, it would have been unethical to
stop interventions in order to study the “natural history”
of oliguria.
Univariate analysis suggested that patient characteris-
tics such as hemodynamic status and physician response
to oliguria were associated with the development of
AKI-Cr; however, these factors are highly interdepen-
dent and the true significance of individual variables is
difficult to assess. We were not able to better define the
nature of these associations in multi-variate analysis as
the small number of patients developing AKI-Cr and
the high degree of co-linearity between hemodynamic
variables and interventions preclude development of a
statistically meaningful model from our dataset. Oliguria
not associated with subsequent AKI based on sCr
changes is likely still to be clinically significant and has
been associated with adverse outcomes [23,24]. This
may be related to better diagnostic sensitivity for the
diagnosis of AKI or oliguria merely acting as a marker
of global hemodynamic instability and illness severity.
This study does not examine the wider implications of
oliguria on outcomes or treatment and is limited to its
association with AKI-Cr.
The results of this study should be taken not to dis-
miss, but to strengthen, the existing role of urine output
in hemodynamic assessment and management in the
ICU. However, they do indicate that, with standard
treatment, most cases of oliguria are not associated with
subsequent AKI-Cr in the ICU, and consequently, that
trials of novel nephro-protective therapies, which aim to
intervene early in the process of kidney injury should
not use oliguria alone as a trigger for recruitment.
Future studies
Use of oliguria alone may be insufficiently precise to be
used as a trigger for intervention in trials of novel pro-
tective interventions. However, it may be more signifi-
cant in the context of concomitant hemodynamic
instability. Furthermore, the use of novel blood or urine
biomarkers of AKI may increase diagnostic yield. Thus,
future studies should focus on determining the com-
bined predictive value of oliguria, clinical variables, stan-
dard urinary biochemistry, and novel biomarkers in the
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early diagnosis of AKI [40,43]. If this combination was
shown to have good predictive value, it could be used as
recruitment criterion in future early interventional trials
of renal protection in the ICU.
Conclusions
Oliguria is significantly associated with the occurrence of
new AKI-Cr; however, most episodes of oliguria are not
followed by biochemical evidence of renal injury. Oliguria
alone is at best only a fair predictor of AKI-Cr. However,
in the presence of hemodynamic compromise or increas-
ing vasopressor dose, it may represent a clinically useful
screening test to trigger other early biomarkers of renal
injury with the goal of achieving a more accurate and
timely identification of patients at risk of AKI.
Key messages
• More patients develop AKI outside the ICU and
present with it rather than developing AKI while in
ICU.
• Using oliguria in isolation as a trigger for interven-
tion in ICU might lead to some patients receiving
unnecessary intervention and other patients not
receiving potentially helpful intervention.
• Oliguria is relatively frequent in ICU patients and
most episodes are not followed by AKI.
• Oliguria has only a fair predictive ability for subse-
quent AKI and lacks clinical utility as a test at the
observed frequencies of AKI in the ICU.
• Oliguria accompanied by hemodynamic compro-
mise or increasing vasopressor dose may represent a
clinically useful trigger for other early biomarkers of
renal injury with the goal of achieving a more accu-
rate and timely identification of patients at risk of
AKI.
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